Medisse has completed its move to its new premises in Leusden, bringing the whole company to one location. The overall increase of space will be a key cont… read more
Medisse is pleased to announced that its shareholders have appointed Alexander Vos to its Supervisory Board. Mr. Vos is currently CEO of Pharmacell , a com… read more
Medisse has successfully completed the biocompatibility evaluation of its novel resorbable FlexiSurge® biomaterial in accordance with the international ISO… read more
Medisse is happy to announce that it received a grant "Overijssel innoveert verder" from the local authorities from the Dutch province Overijssel. read more
Medisse announced today the closure of an equity financing round by BioGeneration Ventures and Crédit Agricole Private Equity. read more
Poly(1,3-trimethylene carbonate) networks as anti adhesion barriers, S.V.N. de Vos, B.W. Hellebrekers, D.W. Grijpma, J. Feijen. read more
Article: S.V.N. de Vos, S.A. Koopmans, J.M.M. Hooymans, J. Feijen, D.W. Grijpma, Poly(1,3-trimethylene carbonate) networks as a resorbable scleral buckle, … read more
Prof. dr. P.A.M. Vierhout, surgeon and general president of the 'Orde van Medisch Specialisten' has become member of the Board of Advisors. read more
Medisse receives BioPartner First Stage Grant. read more